2017-2021 US Tumor Markers Testing Market: Supplier Shares by Test, and Market Segment Sales Forecasts

January 2017 | 40 pages | ID: UC77F25206CEN
Venture Planning Group

Abstracts

This report provides an overview of the US cancer diagnostics market, including market shares of leading suppliers by test, as well as volume and sales forecasts by market segment.

Contents

Business Environment
  1. HEALTH CARE EXPENDITURES
  2. COST CONSCIOUSNESS
  3. INDUSTRY CONSOLIDATION
  4. MANAGED CARE
  5. HOSPITALS
  6. ADMISSIONS
  7. LENGTH OF STAY
  8. INDUSTRY DIVERSIFICATION
  9. PHYSICIAN DEMOGRAPHICS
  10. POPULATION AGING
    a. Chronic Illness
    b. Disease Incidence
    c. Susceptibility to Iatrogenesis
    d. Multiple Illness Cases
  11. LABORATORY REGULATIONS
Market Structure
  1. CENTRALIZED TESTING
    a. Hospitals
    b. Commercial/Private Laboratories
  2. DECENTRALIZED TESTING
    a. Physician Offices/Group Practices
    b. Cancer Clinics     c. Point of Care Testing
    d. Other Decentralized Testing Locations
Market Size, Growth, and Major Suppliers’ Market Shares

LIST OF TABLE

Test Volume Forecast by Market Segment
Sales Forecasts by Market Segment
AFP Testing: Market Shares of Major Suppliers
CA 153/2729 Testing: Market Shares of Major Suppliers
CA 199 Testing: Market Shares of Major Suppliers
CEA Testing: Market Shares of Major Suppliers
PSA Testing: Market Shares of Major Suppliers